About UOC Oncologia Medica, Azienda ULSS21 di Legnago
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at UOC Oncologia Medica, Azienda ULSS21 di Legnago
During the past decade, UOC Oncologia Medica, Azienda ULSS21 di Legnago conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UOC Oncologia Medica, Azienda ULSS21 di Legnago"
#1 collaborator was "Clirest s.r.l." with 2 trials as a collaborator, "Temas srl" with 2 trials as a collaborator, "Arithmos srl" with 1 trials as a collaborator, "Istituto Toscano Tumori" with 1 trials as a collaborator and "Mipharm S.p.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at UOC Oncologia Medica, Azienda ULSS21 di Legnago
According to Clinical.Site data, the most researched conditions in "UOC Oncologia Medica, Azienda ULSS21 di Legnago" are
"Cancer, Breast" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "UOC Oncologia Medica, Azienda ULSS21 di Legnago" in a lesser frequency.
Clinical Trials Intervention Types at UOC Oncologia Medica, Azienda ULSS21 di Legnago
Most popular intervention types in "UOC Oncologia Medica, Azienda ULSS21 di Legnago" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (1 trials), "Nabpaclitaxel" (1 trials), "Pertuzumab" (1 trials), "Trastuzumab IV" (1 trials) and "Trastuzumab SC" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UOC Oncologia Medica, Azienda ULSS21 di Legnago
The vast majority of trials in "UOC Oncologia Medica, Azienda ULSS21 di Legnago" are
2 trials for "All" genders.
Clinical Trials Status at UOC Oncologia Medica, Azienda ULSS21 di Legnago
Currently, there are NaN active trials in "UOC Oncologia Medica, Azienda ULSS21 di Legnago".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in UOC Oncologia Medica, Azienda ULSS21 di Legnago,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UOC Oncologia Medica, Azienda ULSS21 di Legnago, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".